Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Gina Ferrazzano"'
Autor:
Giorgio Leodori, Marco Mancuso, Davide Maccarrone, Matteo Tartaglia, Antonio Ianniello, Francesco Certo, Gina Ferrazzano, Leonardo Malimpensa, Daniele Belvisi, Carlo Pozzilli, Alfredo Berardelli, Antonella Conte
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Motor fatigue in Multiple Sclerosis (MS) is due to reduced motor cortex (M1) output and altered sensorimotor network (SMN) modulation. Natalizumab, a disease-modifying therapy, reduces neuroinflammation and improves fatigue. However, some pa
Externí odkaz:
https://doaj.org/article/6c0eebf121d8490ebeb62a1a97030d31
Autor:
Tommaso Gosetti di Sturmeck, Leonardo Malimpensa, Gina Ferrazzano, Daniele Belvisi, Giorgio Leodori, Flaminia Lembo, Rossella Brandi, Esterina Pascale, Antonino Cattaneo, Marco Salvetti, Antonella Conte, Mara D’Onofrio, Ivan Arisi
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 12, p 6342 (2024)
The current hypothesis on the pathophysiology of multiple sclerosis (MS) suggests the involvement of both inflammatory and neurodegenerative mechanisms. Disease Modifying Therapies (DMTs) effectively decrease relapse rates, thus reducing relapse-asso
Externí odkaz:
https://doaj.org/article/aba4bbb04f0445e7a175732e6b01cdf1
Autor:
Ivan Arisi, Leonardo Malimpensa, Valeria Manzini, Rossella Brandi, Tommaso Gosetti di Sturmeck, Chiara D’Amelio, Sebastiano Crisafulli, Gina Ferrazzano, Daniele Belvisi, Francesca Malerba, Rita Florio, Esterina Pascale, Hermona Soreq, Marco Salvetti, Antonino Cattaneo, Mara D’Onofrio, Antonella Conte
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Background and objectivesMultiple sclerosis (MS) is a chronic, progressive neurological disease characterized by early-stage neuroinflammation, neurodegeneration, and demyelination that involves a spectrum of heterogeneous clinical manifestations in
Externí odkaz:
https://doaj.org/article/fd58ef36b5ed4df88fb3c4411a2e547d
Autor:
Valentina Perri, Maria Antonella Zingaropoli, Patrizia Pasculli, Federica Ciccone, Matteo Tartaglia, Viola Baione, Leonardo Malimpensa, Gina Ferrazzano, Claudio Maria Mastroianni, Antonella Conte, Maria Rosa Ciardi
Publikováno v:
Biology, Vol 13, Iss 3, p 154 (2024)
Multiple sclerosis (MS) is a debilitating neurological disease that has been classified as an immune-mediated attack on myelin, the protective sheath of nerves. Some aspects of its pathogenesis are still unclear; nevertheless, it is generally establi
Externí odkaz:
https://doaj.org/article/8a799737bd8b47c4a85ab665ca20db4a
Autor:
Giorgio Leodori, Marco Mancuso, Davide Maccarrone, Matteo Tartaglia, Antonio Ianniello, Francesco Certo, Viola Baione, Gina Ferrazzano, Leonardo Malimpensa, Daniele Belvisi, Carlo Pozzilli, Alfredo Berardelli, Antonella Conte
Publikováno v:
Neurobiology of Disease, Vol 180, Iss , Pp 106073- (2023)
Motor fatigue is one of the most common symptoms in multiple sclerosis (MS) patients. Previous studies suggested that increased motor fatigue in MS may arise at the central nervous system level. However, the mechanisms underlying central motor fatigu
Externí odkaz:
https://doaj.org/article/b4449874a10843598f4fa57d598a1486
Autor:
Carolina Cutrona, Francesco Marchet, Matteo Costanzo, Maria Ilenia De Bartolo, Giorgio Leodori, Gina Ferrazzano, Antonella Conte, Giovanni Fabbrini, Alfredo Berardelli, Daniele Belvisi
Publikováno v:
Toxins, Vol 16, Iss 1, p 9 (2023)
Botulinum toxin (BoNT) is an effective and safe therapy for the symptomatic treatment of several neurological disturbances. An important line of research has provided numerous pieces of evidence about the mechanisms of action of BoNT in the central n
Externí odkaz:
https://doaj.org/article/fac211e0f8cb4069b96847c9aec22a8d
Autor:
Matteo Tartaglia, Marco Canevelli, Leonardo Malimpensa, Daniele Belvisi, Viola Baione, Gina Ferrazzano, Giorgio Leodori, Alfredo Berardelli, Antonella Conte
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Timely diagnosis of secondary progressive multiple sclerosis (SPMS) represents a clinical challenge. The Frailty Index, a quantitative frailty measure, and the Neurophysiological Index, a combined measure of sensorimotor cortex inhibitory mechanism p
Externí odkaz:
https://doaj.org/article/924aa9f20fce4ee28ac635e1b0a88acc
Autor:
Giorgio Leodori, Marco Mancuso, Davide Maccarrone, Matteo Tartaglia, Viola Baione, Antonio Ianniello, Gina Ferrazzano, Alfredo Berardelli, Carlo Pozzilli, Antonella Conte
Publikováno v:
Brain Stimulation, Vol 16, Iss 1, Pp 298- (2023)
Externí odkaz:
https://doaj.org/article/12dd5752f547462a9fbf7bb218e2a49d
Autor:
Giovanni Mostile, Christian Geroin, Roberto Erro, Antonina Luca, Enrico Marcuzzo, Paolo Barone, Roberto Ceravolo, Sonia Mazzucchi, Andrea Pilotto, Alessandro Padovani, Luigi Michele Romito, Roberto Eleopra, Carlo Dallocchio, Carla Arbasino, Francesco Bono, Pietro Antonio Bruno, Benedetta Demartini, Orsola Gambini, Nicola Modugno, Enrica Olivola, Laura Bonanni, Alberto Albanese, Gina Ferrazzano, Rosa De Micco, Maurizio Zibetti, Giovanna Calandra-Buonaura, Martina Petracca, Francesca Morgante, Marcello Esposito, Antonio Pisani, Paolo Manganotti, Fabrizio Stocchi, Mario Coletti Moja, Ilaria Antonella Di Vico, Lucia Tesolin, Francesco De Bertoldi, Tommaso Ercoli, Giovanni Defazio, Mario Zappia, Alessandra Nicoletti, Michele Tinazzi
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
IntroductionFunctional Motor Disorders (FMDs) represent nosological entities with no clear phenotypic characterization, especially in patients with multiple (combined FMDs) motor manifestations. A data-driven approach using cluster analysis of clinic
Externí odkaz:
https://doaj.org/article/0f90aa4aff3347918f44025e44038ef5
Autor:
Maria Antonella Zingaropoli, Patrizia Pasculli, Matteo Tartaglia, Federica Dominelli, Federica Ciccone, Ambra Taglietti, Valentina Perri, Leonardo Malimpensa, Gina Ferrazzano, Marco Iannetta, Cosmo Del Borgo, Miriam Lichtner, Claudio Maria Mastroianni, Antonella Conte, Maria Rosa Ciardi
Publikováno v:
Biology, Vol 12, Iss 4, p 587 (2023)
Background: The anti-CD20 monoclonal antibody ocrelizumab has been widely employed in the treatment of people with multiple sclerosis (pwMS). However, its B-cell-depleting effect may induce a higher risk of infectious events and alterations in the se
Externí odkaz:
https://doaj.org/article/b160963e955e4716a08664940f412a63